HAELO Trademark

Trademark Overview


On Friday, March 22, 2024, a trademark application was filed for HAELO with the United States Patent and Trademark Office. The USPTO has given the HAELO trademark a serial number of 98463858. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, October 7, 2024. This trademark is owned by Intellia Therapeutics, Inc.. The HAELO trademark is filed in the Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Organizing and recruiting patients for clinical trials for the treatment of hereditary angioedema (HAE) using in vivo gene editing technology

Medical treatment of hereditary angioedema (HAE) using in vivo gene editing technology

Scientific research in the nature of conducting clinical trials for the treatment of hereditary angioedema (HAE) using in vivo gene editing technology
haelo

General Information


Serial Number98463858
Word MarkHAELO
Filing DateFriday, March 22, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, October 7, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the word "HAELO" with lettering in blue and light blue, with two rows of small rectangular shapes forming a semi-circle appearing above, the top row in yellow and the bottom row in red-orange.
Indication of Colors claimedThe color(s) blue, light blue, yellow, and red-orange is/are claimed as a feature of the mark.
Goods and ServicesOrganizing and recruiting patients for clinical trials for the treatment of hereditary angioedema (HAE) using in vivo gene editing technology
Goods and ServicesMedical treatment of hereditary angioedema (HAE) using in vivo gene editing technology
Goods and ServicesScientific research in the nature of conducting clinical trials for the treatment of hereditary angioedema (HAE) using in vivo gene editing technology

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, March 22, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 22, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 22, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIntellia Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Friday, March 22, 2024NEW APPLICATION ENTERED
Tuesday, August 20, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, October 7, 2024NON-FINAL ACTION E-MAILED
Monday, October 7, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 7, 2024NON-FINAL ACTION WRITTEN
Tuesday, October 1, 2024ASSIGNED TO EXAMINER
Tuesday, August 20, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED